Skip to main content

Athira Pharma's stock plummets after disappointing drug trial results

The company's lead drug didn't produce a significant change in working memory speed or cognition compared with a placebo.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.